The digital asthma self-management program significantly improved symptom control, especially for those with uncontrolled asthma, showing a 2.8-point Asthma Control Test score difference over usual ...

Please provide your email address to receive an email when new articles are posted on . Patients are prone to airway contraction when cells lose cyclic adenosine monophosphate. Patients with asthma ...

An asthma self-management app paired with wearables improved asthma control for adults in a randomized controlled trial. African American patients gained less from the digital intervention. The study ...

Please provide your email address to receive an email when new articles are posted on . Bifidobacterium infantis 35624 can decrease levels of dysfunctional T regulatory cells. There were no ...

asthma, lungs Authors review changes in the diagnosis, workup, and treatment of asthma in the 2022 GINA report. Some patients with asthma who lack evidence of type 2 inflammation are considered to ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window The ...

Asthma care continues to develop, particularly in how treatment and long-term management are approached. This article outlines current treatment and management recommendations for patients aged 12 and ...

Elevance Health and UC Irvine study underscores potential of digital health tools to reduce asthma burden across U.S. populations INDIANAPOLIS--(BUSINESS WIRE)--A groundbreaking clinical trial led by ...

In adults with asthma, a digital asthma self-management (DASM) program improved symptom control compared with usual care, although its effectiveness varied by race, with weaker results observed among ...

Tezspire (tezepelumab-ekko) is a monthly injection used to treat severe asthma. It was approved by the FDA in 2021 for use in addition to other asthma controlling medicines in people 12 and older.